Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Cash flows from operating activities:
Net earnings	$ 622	$ 469
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	205	209
Stock-based compensation expense	177	167
Restructuring and other charges	63	141
Deferred taxes on earnings	(5)	(140)
Other, net	(20)	4
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	446	244
Inventory	(47)	230
Accounts payable	(744)	(1,731)
Net investment in leases	(62)	(16)
Taxes on earnings	49	220
Restructuring and other	(87)	(92)
Other assets and liabilities	(476)	279
Net cash provided by (used in) operating activities	121	(16)
Cash flows from investing activities:
Investment in property, plant and equipment, net	(158)	(192)
Purchases of available-for-sale securities and other investments	0	(4)
Maturities and sales of available-for-sale securities and other investments	0	1
Collateral posted for derivative instruments	(70)	(240)
Net cash used in investing activities	(228)	(435)
Cash flows from financing activities:
Proceeds from short-term borrowings with original maturities less than 90 days, net	100	200
Proceeds from debt, net of issuance costs	92	52
Payment of debt and associated costs	(49)	(539)
Stock-based award activities and others	(76)	(79)
Repurchase of common stock	(500)	(100)
Cash dividends paid	(275)	(259)
Collateral returned for derivative instruments	0	(200)
Net cash used in financing activities	(708)	(925)
Decrease in cash, cash equivalents and restricted cash	(815)	(1,376)
Cash, cash equivalents and restricted cash at beginning of period	3,232	3,145
Cash, cash equivalents and restricted cash at end of period	$ 2,417	$ 1,769